A 62-year-old female patient with recurrent atrial fibrillation and hypertrophic obstructive cardiomyopathy, who had ...
The regulatory authorizations come as Medtronic looks to differentiate itself in the fast-growing pulsed field ablation ...
Napoli have been handed a significant boost as Scott McTominay has officially returned to the training pitch following his ...
When doctors destroy a liver tumor with heat instead of surgery, the entire battle is won or lost by millimeters. Thermal ...
September marks Pain Awareness Month, a time dedicated to patients living with chronic pain and to advocating for proper ...
A noninvasive neurosurgical procedure that delivers radiation to a specific brain pathway significantly reduced symptoms of ...
FDA clearance and CE Mark for latest Affera™ Prism-2 Mapping Software expand cardiac mapping capabilities. CE Mark for ...
Medtronic's latest regulatory wins further support its fast-growing arrhythmia-treating cardiac ablation business.
As Boston Scientific, Medtronic, Abbott, and J&J battle for PFA market share, Pulse Biosciences could rewrite the competitive ...
LAVA-CRLM: SBRT vs Microwave Ablation in Oligometastatic Colorectal Liver Metastases / cancer, cancer care, Cancer research, ...
Medtronic declared a $0.72 quarterly dividend and won FDA clearance and CE marking for Affera Prism-2, plus CE certification for PulseSelect ProxBox.
The heart procedure is the latest in a series of health scares for the musician. Last month, Richie spent three days in an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results